InVivo Therapeutics adds UVA Health System as INSPIRE study site: 4 takeaways

Spinal Tech

InVivo Therapeutics added University of Virginia Health System in Charlottesville as a clinical site for the INSPIRE study.

Here are four takeaways:

 

1. The INSPIRE study examines the potential benefit of InVivo's Neuro-Spinal Scaffold.

 

2. The Neuro-Spinal Scaffold is an investigational device, and it has received a Humanitarian Use Device designation.

 

3. The implantable scaffold is intended to reduce post-traumatic cavity formation and allow neural regeneration after acute spinal cord injury.

 

4. There are now 19 clinical sites participating in the clinical study.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers